Deleted in esophageal cancer 1(DEC1) is down-regulated and contributes to migration in head and neck squamous cell carcinoma cell lines

ORL

Volumn 73, Issue 1, 2011, Pages 17-23

  Kunimoto, Yasuomi ^a   Nakano, Seiji ^b,c   Kataoka, Hideyuki ^a   Shimada, Yutaka ^d   Oshimura, Mitsuo ^b   Kitano, Hiroya ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

DEC1; Head and neck squamous cell carcinoma; Histone H3 K27 trimethylation; Invasion; Migration; Tumor suppressor gene

Indexed keywords

HISTONE H3;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELETED IN ESOPHAGEAL CANCER 1 GENE; DOWN REGULATION; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HISTONE MODIFICATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HISTONES; HUMANS; METHYLATION; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 77958147931     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320997     Document Type: Article

References (22)

1. Kim MM, Califano JA: Molecular pathology of head-and-neck cancer. Int J Cancer 2004; 112:545-553.
2. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A: An allelotype of squamous carcinoma of the head and neck using mi-crosatellite markers. Cancer Res 1994; 54: 1617-1621.
3. Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q: The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esoph-ageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 2007; 26: 934-944.
4. Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM: Gene amplification and overex-pression of protein phosphatase 1α in oral squamous cell carcinoma cell lines. Oncogene 2006; 25:5517-5526.
5. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, Bidoli E, Serraino D, La Vecchia C: Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990; 50:6502-6507. (Pubitemid 20348768)
6. Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y: Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esopha-geal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer 2000; 27: 169-176.
7. Izumi H, Inoue J, Yokoi S, Hosoda H, Shibata T, Sunamori M, Hirohashi S, Inazawa J, Imoto I: Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 2005; 14: 997-1007.
8. Lo PH, Leung AC, Kwok CY, Cheung WS, Ko JM, Yang LC, Law S, Wang LD, Li J, Stanbridge EJ, Srivastava G, Tang JC, Tsao SW, Lung ML: Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 2007; 26: 148-157.
9. Gu X, Coates PJ, Boldrup L, Nylander K: p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck. Cancer Lett 2008; 263: 26-34.
10. Komatsu S, Imoto I, Tsuda H, Kozaki KI, Muramatsu T, Shimada Y, Aiko S, Yoshizumi Y, Ichikawa D, Otsuji E, Inazawa J: Over-expression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squa mous cell carcinoma. Carcinogenesis 2009; 30:1139-1146.
11. Daigo Y, Suzuki K, Maruyama O, Miyoshi Y, Yasuda T, Kabuto T, Imaoka S, Fujiwara T, Takahashi E, Fujino MA, Nakamura Y: Isolation, mapping and mutation analysis of a human cDNA homologous to the doc-1 gene of the Chinese hamster, a candidate tumor suppressor for oral cancer. Genes Chromosomes Cancer 1997; 20:204-207.
12. Yang L, Leung AC, Ko JM, Lo PH, Tang JC, Srivastava G, Oshimura M, Stanbridge EJ, Daigo Y, Nakamura Y, Tang CM, Lau KW, Law S, Lung ML: Tumor suppressive role of a 2. 4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 2005; 24: 697-705.
13. Leung AC, Wong VC, Yang LC, Chan PL, Daigo Y, Nakamura Y, Qi RZ, Miller LD, Liu ET, Wang LD, Li JL, Law S, Tsao SW, Lung ML: Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer 2008; 122: 587-594.
14. Kawabe A, Shimada Y, Soma T, Maeda M, Itami A, Kaganoi J, Kiyono T, Imamura M: Production of prostaglandin E2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells. Life Sci 2004; 75: 21-34.
15. Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC: Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypo-acetylation in human epithelial ovarian cancer. Neoplasia 2006; 8:268-278.
16. Suzuki K, Daigo Y, Fukuda S, Tokino T, Isomura M, Isono K, Wainwright B, Nakamura Y: No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung. Jpn J Cancer Res 1997; 88:225-228.
17. Kubicek S, Jenuwein T: A crack in histone ly-sine methylation. Cell 2004; 119:903-906.
18. Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA, Kelly TA, Jenuwein T: Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 2007; 25:473-481.
19. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y: Role of histone h3 lysine 27 methylation in polycomb-group silencing. Science 2002; 298:1039-1043.
20. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, Bergman Y, Simon I, Cedar H: Polycombmediated methylation on lys27 of histone h3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232-236.
21. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP: Gene silencing in cancer by histone H3 lysine 27 trimethyl-ation independent of promoter DNA meth-ylation. Nat Genet 2008; 40:741-750.
22. Watanabe H, Soejima K, Yasuda H, Kawada I, Nakachi I, Yoda S, Naoki K, Ishizaka A: Deregulation of histone lysine methyltrans-ferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 2008; 8:15.